inclusion criteria: 1. male or female subjects aged ≥18 years at screening; 2. those females who do not have plans for pregnancy within six months and are willing to take effective contraceptive measures from the first dose of the study drug to 3 months after the last dose; 3. if male, agree to use adequate contraception throughout the study and for at least 3 months after the last dose of study drug; 4. has a documentation of pcr-confirmed sars-cov-2 infection with sample collection ≤5 days prior to randomization.

inclusion criteria: 1. male or female subjects aged ≥18 years at screening; 2. those females who do not have plans for pregnancy within six months and are willing to take effective contraceptive measures from the first dose of the study drug to 3 months after the last dose; 3. if male, agree to use adequate contraception throughout the study and for at least 3 months after the last dose of study drug; 4. has a documentation of pcr-confirmed sars-cov-2 infection with sample collection ≤5 days prior to randomization.

inclusion criteria: male or female subjects aged ≥18 years at screening; those females who do not have plans for pregnancy within six months and are willing to take effective contraceptive measures from the first dose of the study drug to 3 months after the last dose; if male, agree to use adequate contraception throughout the study and for at least 3 months after the last dose of study drug; has a documentation of pcr-confirmed sars-cov-2 infection with sample collection ≤5 days prior to randomization.

inclusion criteria: male or female subjects aged ≥18 years at screening; those females who do not have plans for pregnancy within six months and are willing to take effective contraceptive measures from the first dose of the study drug to 3 months after the last dose; if male, agree to use adequate contraception throughout the study and for at least 3 months after the last dose of study drug; has a documentation of pcr-confirmed sars-cov-2 infection with sample collection ≤5 days prior to randomization.